Emergency Contraceptive - Prescriber
  • Safe and effective up to 72 hours (3 days) after an unprotected sexual encounter has occurred
  • Simple 1-dose, 1-pill regimen
  • Progestin-only pill, bioequivalent to
    Plan B One-Step®
  • Available without a prescription for women 17 years of age or older. A prescription is required for women younger than 17 years of age

Because She Has an Option

According to 2001 data, about half of 6.4 million pregnancies in the United States are unintended, and more than 1.3 million pregnancies are prematurely terminated each year.1 Facing an unintended pregnancy after unprotected sex or contraceptive failure can be difficult for your patients and they may look to you for information and guidance.

Emergency contraception is one option you may want to discuss with them. Taken within the days immediately following unprotected sex, emergency contraception can reduce the likelihood that a woman will become pregnant.2

Next Choice One Dose™ is a generic emergency contraceptive pill (bioequivalent to Plan B One-Step®).3 It is available behind the pharmacy counter and sold under a licensed pharmacist’s supervision, providing women 17 years of age or older with an accessible, easy-to-take emergency-contraception option. Only women younger than 17 years of age require a prescription.4

Important Safety Information

Next Choice One Dose™ is a progestin-only emergency contraceptive indicated for prevention of pregnancy after unprotected intercourse or known or suspected contraceptive failure. Next Choice One Dose™ is only available without a prescription for women 17 years of age or older. Women younger than 17 years of age require a prescription. Next Choice One Dose™ is contraindicated for use in the case of known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice One Dose™ should be evaluated for an ectopic pregnancy. Next Choice One Dose™ is not effective in terminating an existing pregnancy. If the next expected menses is delayed beyond 1 week after use of Next Choice One Dose™, pregnancy should be considered. Next Choice One Dose™ does not protect against HIV or other sexually transmitted diseases (STDs). Next Choice One Dose™ contains FD&C Yellow #6 as a color additive. The most common adverse reactions in clinical trials included heavier menstrual bleeding (31%), nausea (14%), lower abdominal pain (13%), fatigue (13%), headache (10%), and dizziness (10%). If vomiting occurs within 2 hours of taking Next Choice One Dose™, consideration should be given to repeating the dose.

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice One Dose™, please call our Medical Communications Department at 1-866-9WATSON or see full Prescribing Information.

References: 1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90-96. 2. American College of Obstetricians and Gynecologists. Latest options in EC: a resource guide for health care providers and their patients on emergency contraception. 2009. 3. US Department of Health & Human Services, US Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Database). Silver Spring, MD. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. Accessed May 14, 2012. 4. Next Choice One Dose™ full Prescribing Information, Watson Pharma, Inc. 2012.

Registered trademarks are the property of their respective owners.

b %>